NOAEL Studies
Cosmetic Ingredient
Hydroxyethoxy Aminopyrazolopyridine HCl NOAEL Studies
INCI: HYDROXYETHOXY AMINOPYRAZOLOPYRIDINE HCL
CAS: 1079221-49-0
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =1.67 | mg/kg bw/d | human | oral | prenatal | developmental toxicity | p.24 |
| SCCS Opinion | NOAEL | =3.33 | mg/kg bw/d | human | oral | prenatal | developmental toxicity | p.24 |
| SCCS Opinion | NOAEL | =10 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.18 |
| SCCS Opinion | NOAEL | =10 | mg/kg/day | - | - | developmental | developmental toxicity | p.23 |
| SCCS Opinion | NOAEL | =30 | mg/kg bw/day | rat | oral | 90-day | developmental toxicity | p.25 |
| SCCS Opinion | NOAEL | =100 | mg/kg bw/day | rat | - | - | NOAEL study | p.17 |
ECHA 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ECHA | NOAEL | =30 | mg/kg bw/day | Rat | oral | subchronic; 13 weeks | subchronic | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eaccce4b0a7c65d1c0e1d; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/en/registration-dossier/-/registered-dossier/5635?documentUUID=f8f19aa2-0938-4cfc-b1b4-f291d972f227; YEAR=2006; ORIGINAL_YEAR=2006; STUDY_GROUP=ECHA IUCLID:15841896:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_f1a298213527a681bc0011059e98e8de |
Regulatory source 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 100 | mg/kg bw/day | rat | - | - | - | p.17 |
| Regulatory source | dermal absorption | 10 | mg/kg bw/day | human | dermal | - | dermal absorption | p.24 |
| Regulatory source | developmental toxicity | =1.67 | mg/kg bw/d | human | oral | prenatal | developmental toxicity | p.24 |
| Regulatory source | developmental toxicity | =3.33 | mg/kg bw/d | human | oral | prenatal | developmental toxicity | p.24 |
| Regulatory source | developmental toxicity | 10 | mg/kg/day | - | - | developmental | developmental toxicity | p.23 |
| Regulatory source | developmental toxicity | 10 | mg/kg bw/day | rat | oral | 90-day | developmental toxicity | p.25 |
| Regulatory source | developmental toxicity | 30 | mg/kg bw/day | rat | oral | 90-day | developmental toxicity | p.25 |
| Regulatory source | genotoxicity | 10 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.18 |